Physician

Thomas Tien, M.D.

According to 2025 Medicare claims, Thomas Tien, M.D. (NPI: 1700234051) practices ophthalmology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is FRANCIS J MANNING MD PC (NPI: 1720005465; TIN: 522406923) and primary practice location at 17603-7600. Tien is affiliated with the Keystone ACO (ACO ID: A1552) and Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Tien's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 861 HCPCS/CPT codes, and received $109,828 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,057 prescription claims across 367 beneficiaries totaling $268,951 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 6 records totaling $406. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,480 to $109,828. Similarly, Part D prescription costs have moved sharply higher in recent years, from $166 to $268,951. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$55K$110K2020 Medicare payment: $5,480 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $48,522 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $85,236 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $108,909 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $109,828 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204447$5,480
2021233418$48,522
2022264759$85,236
2023275848$108,909
2024323861$109,828

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$134K$269K2016 Drug cost: $166 (USD; Tot_Drug_Cst)2017 Drug cost: $6,626 (USD; Tot_Drug_Cst)2018 Drug cost: $26,588 (USD; Tot_Drug_Cst)2019 Drug cost: $24,053 (USD; Tot_Drug_Cst)2020 Drug cost: $52,458 (USD; Tot_Drug_Cst)2021 Drug cost: $21,764 (USD; Tot_Drug_Cst)2022 Drug cost: $175,372 (USD; Tot_Drug_Cst)2023 Drug cost: $188,134 (USD; Tot_Drug_Cst)2024 Drug cost: $268,951 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R11$166
201761201$6,626
2018132457$26,588
2019148464$24,053
2020162756$52,458
2021148326$21,764
2022259794$175,372
2023239782$188,134
20243671,057$268,951

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens64107$388
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6262$83
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more172309$66
92014Established patient complete exam of visual system4848$52
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4349$43

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine623,780$28,042
RestasisCyclosporine181,140$22,756
Prednisolone AcetatePrednisolone Acetate31611,971$14,476
XiidraLifitegrast11450$9,886
Timolol MaleateTimolol Maleate713,442$3,658

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$406BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Tien, M.D.?

Tedicare shows public-source Medicare data for Thomas Tien, M.D. (NPI 1700234051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Tien, M.D. have ACO affiliation data?

Thomas Tien, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Thomas Tien, M.D.?

Thomas Tien, M.D. is linked to FRANCIS J MANNING MD PC (billing NPI 1720005465) in the available physician profile data.

Does Thomas Tien, M.D. have Open Payments data?

Thomas Tien, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.